22 April 2012

Postdoctoral application (Sara Borrell)


IDIBELL
Contacto correo-e: mapujana@iconcologia.net

We seek for an excellent and highly motivated postdoc that is willing to apply for a “Sara Borrell” contract with our research group (please see
http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/fd-convocatorias-ayudas-accion-estrategica-salud/lineas-actuacion.shtml.
The ideal candidate should be self-motivated and independent, and have strong academic training in biochemistry and cancer cell biology. Applicants must have have first-authored publications in respected journals. The research group is situated within the Catalan Institute of Oncology (Bellvitge Institute for Biomedical Research, IDIBELL). The Institute offers strong interactive environment and various excellent opportunities for collaborative research exists within the institute and the surrounding Hospital area. Interested applicants are encouraged to apply with an email containing your curriculum vitae, and names and contact information of two references to Miquel Àngel Pujana via e-mail: mapujana@iconcologia.net.

Información complementaria de la oferta:
Recent publications by the group:
Maxwell et al. (2011). Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. PLoS Biology Nov;9(11):e1001199.
Martrat et al. (2011). Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research 13(2):R40.
Aguilar et al. (2010). Biological reprogramming in acquired resistance to endocrine treatment of breast cancer. Oncogene 29(45):6071-83.

No comments: